Clinical Trials Logo
  1. Home
  2. Spondylarthritis
  3. NCT04964661

Incidence of MRI Sacro-Iliac (SI) Joint Anomalies in Women With Spondyloarthritis (SpA) — MISIA 2  

Spondylarthritis Clinical Trial

Official title:
Incidence of Sacro-iliac (SI) Joint Anomalies on MRI: Differentiation Criteria in Women With Spondyloarthritis (SpA

Clinical Trial Summary

Retrospective study comparing the incidence of inflammatory and structural lesions seen on MRI of the sacro-iliac (SI) joints in a population of women affected by spondyloarthritis (SpA) and control women population (MISIA study NCT02956824). A previous study (MISIA) demonstrate SpA may be misdiagnosed on MRI in postpartum women due to increased stress on the joint following pregnancy and childbirth, as MRI of the SI joints may show lesions that could mimics SpA. The primary objective of this study is to compare the incidence and pattern of MRI inflammatory and structural lesions of the SI joints between SpA and control women, and determine differentiation criteria in SpA women.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04964661
Study type Observational
Source University Hospital, Montpellier
Contact
Status Enrolling by invitation
Phase
Start date June 1, 2021
Completion date March 30, 2022
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05494203 - Multi-omics Study and Drug Intervention Study of Spondyloarthritis
Completed NCT03818958 - Seric Calprotectine in Spondyloarthritis
Not yet recruiting NCT03940911 - Fatigue and Skeletal Muscle Impact in Severe Axial Spondylarthritis N/A
Completed NCT01947465 - Immunogenicity and Safety of Vaccinations in Immunocompromised Persons N/A
Recruiting NCT05926453 - Assessment of Cardiorespiratory Fitness in Spondylarthritis
Recruiting NCT05080218 - COVID-19 VaccinE Response in Rheumatology Patients Phase 4
Terminated NCT03454932 - Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
Completed NCT01314547 - Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort N/A
Not yet recruiting NCT06273306 - Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC) N/A
Recruiting NCT02809781 - A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis Phase 2/Phase 3
Completed NCT02098694 - Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis N/A
Recruiting NCT00491933 - Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists N/A
Completed NCT02473315 - Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis N/A
Completed NCT03999489 - Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain
Recruiting NCT04519866 - Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA) N/A
Completed NCT02402894 - Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
Recruiting NCT05592574 - IL17 Rate and Spondyloarthritis
Completed NCT02988674 - A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
Recruiting NCT05555433 - Calprotectine in Spondyloarthritis
Completed NCT01302730 - Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study N/A